Delivery Order SPE2DX15D2223-SPE2DX24F4FPG
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,055.22 firm fixed price contract is for the delivery of 4,565,631,255 units of Albendazole 200 mg tablets. The contract has an ultimate completion date of August 30, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA to efficiently...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALBENDAZOLE 200 MG TABLET 2S, a medical product, with a ceiling value of $6,646.63 and a period of performance through June 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is a prime contractor that holds a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading pharmaceutical distribution company. The award is for the delivery of Albendazole tablets, a pharmaceutical product, with a potential value of $5,258.40 and a completion date of February 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Albendazole tablets. The $13,576.57 contract has a period of performance through December 28, 2023 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is issued under a larger indefinite delivery contract (IDC) with a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,568,629,405 units of the medication Albendazole 200 mg tablets. The contract has a ceiling value of $10,200.99 and is a firm fixed-price delivery order contract, without any set-aside designation. The ultimate completion date for this order is June 26, 2025. AmerisourceBergen Drug Corp is a for-profit organization that serves as...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ALBENDAZOLE 200 MG TABLET 2S, a pharmaceutical product, with a ceiling value of $1,251.72 and a performance period through July 2, 2025. The contract is a firm fixed-price delivery order, without a set-aside designation, indicating open competition. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,535.30, is for the supply of Albendazole 200 mg tablets to support military healthcare programs. The contract has an ultimate completion date of November 21, 2024 and is a firm fixed-price delivery order. This contract award is not designated with a set-aside requirement, indicating open...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Albendazole 200 mg tablets with a ceiling value of $11,050.69 under firm fixed pricing. This non-set-aside, competitively awarded contract represents a child delivery order issued against AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999.999 billion through December 2026. The place of...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the delivery of Albendazole Tablets, a pharmaceutical product, with a period of performance through March 15, 2024. The ceiling value of this delivery order is $5,258.40, and it is a firm fixed-price contract. AmerisourceBergen, a major pharmaceutical distributor, has a larger Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,051,643 units of the drug Albendazole 200 mg tablets. The $1,809.17 firm fixed-price contract has a completion date of July 3, 2024. Amerisourcebergen has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- SPE2DX15D2223Indefinite Delivery Contract
- SPE2DX15D2223-SPE2DX24F4FPGDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical services company Amerisourcebergen Corporation. The contract is for the supply of Albendazole 200 mg tablets, a pharmaceutical product, with a ceiling value of $13,474.64 and a period of performance through March 29, 2024. This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary contract vehicle for Amerisourcebergen to provide pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has a firm fixed price pricing type and does not utilize any set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.5k | 3/28/24 |